Kailera Therapeutics, Inc.

NASDAQ:KLRA

Biotechnology

Healthcare
$11.79 +2.66%

+$0.51 today

Market cap
$1.53B
Beta
0.00
52W Low $18.50High $28.23

Volume 0.42M

Average 0.80M

Balance Sheet

Inspect the capital base behind the business.

Assets

$692.29M

FY 2025 · Annual

Liabilities

$1.05B

FY 2025 · Annual

Equity

-$356.46M

FY 2025 · Annual

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$130.3M
Short-term Investments$786.4M
Other Current$12.4M
Total Current Assets$929.2M
PP&E (Net)$11.7M
Other Non-current$270.6M
Total Non-current Assets$282.2M
Total Assets$1.2B

Analysis

Selected assets total $1.2B for Latest. The largest visible component is Short-term Investments at $786.4M, about 64.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 4, 2026
8-KCurrent reportNov 4, 2026
3Initial statement of beneficial ownershipSep 9, 2026
4Statement of changes in beneficial ownershipSep 9, 2026
SC 13GSC 13G filingAug 14, 2026

How much cash does KLRA have?

Kailera Therapeutics, Inc. (KLRA) reported $160.27M in cash and equivalents in fiscal 2025.

How much debt does KLRA carry?

Kailera Therapeutics, Inc. (KLRA) reported $10.75M of total debt, with net debt of -$149.51M.